Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Dietary intake of folate, vitamin B6, vitamin B12, and riboflavin and the risk of incident dementia

Abstract

Background/Objectives

Low intake of B vitamins may increase dementia; However, epidemiological evidence, particularly for riboflavin (vitamin B₂), remains sparse. This study aimed to examine the association between dietary intakes of B vitamins (riboflavin, vitamin B6, vitamin B12, and folate) and the incidence of disabling dementia necessitating care under Japan’s national insurance over a 15-year observation period.

Methods

As part of the Circulatory Risk in Communities Study, a prospective study involving a community-based cohort of 4171 Japanese individuals aged 40–69 years was conducted. Dietary intakes of B vitamins were estimated through a single 24-h dietary recall method. Disabling dementia was defined by the daily living disability status related to dementia based on the long-term care insurance system of Japan. Hazard ratios of disabling dementia were estimated using area-stratified Cox proportional hazard models.

Results

Over a median follow-up of 15.4 years, 887 cases of disabling dementia were identified. Riboflavin intake was inversely associated with the risk of disabling dementia; the multivariable hazard ratio for the highest versus lowest quartiles was 0.51 (95% CI 0.42–0.63; P for trend <0.001). A similar inverse association was observed for vitamin B6 and folate intakes, with multivariable hazard ratios of 0.80 (0.66–0.97; P for trend = 0.01) and 0.79 (0.65–0.96; P for trend <0.001), respectively.

Conclusions

Our findings suggest that dietary intake of B vitamins, especially riboflavin, vitamin B6, and folate, is associated with a reduced risk of disabling dementia in Japanese individuals.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Study design for the timing of exposure and outcome.

Similar content being viewed by others

Data availability

The datasets generated during and/or analyzed during the current study are not publicly available but are available from the corresponding author upon reasonable request and with the permission of the cohort committee.

References

  1. Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 2006;5:949–60.

    Article  CAS  PubMed  Google Scholar 

  2. Calderon-Ospina CA, Nava-Mesa MO. B Vitamins in the nervous system: current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin. CNS Neurosci Ther. 2020;26:5–13.

    Article  PubMed  Google Scholar 

  3. Smith AD, Refsum H. Homocysteine, B vitamins, and cognitive impairment. Annu Rev Nutr. 2016;36:211–39.

    Article  CAS  PubMed  Google Scholar 

  4. Powers HJ. Riboflavin (vitamin B-2) and health. Am J Clin Nutr. 2003;77:1352–60.

    Article  CAS  PubMed  Google Scholar 

  5. Moat SJ, Ashfield-Watt PA, Powers HJ, Newcombe RG, McDowell IF. Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype. Clin Chem. 2003;49:295–302.

    Article  CAS  PubMed  Google Scholar 

  6. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med. 2002;346:476–83.

    Article  CAS  PubMed  Google Scholar 

  7. Agnew-Blais JC, Wassertheil-Smoller S, Kang JH, Hogan PE, Coker LH, Snetselaar LG, et al. Folate, vitamin B-6, and vitamin B-12 intake and mild cognitive impairment and probable dementia in the Women’s Health Initiative Memory Study. J Acad Nutr Diet. 2015;115:231–41.

    Article  PubMed  Google Scholar 

  8. Corrada MM, Kawas CH, Hallfrisch J, Muller D, Brookmeyer R. Reduced risk of Alzheimer’s disease with high folate intake: the Baltimore Longitudinal Study of Aging. Alzheimers Dement. 2005;1:11–8.

    Article  CAS  PubMed  Google Scholar 

  9. Luchsinger JA, Tang MX, Miller J, Green R, Mayeux R. Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol. 2007;64:86–92.

    Article  PubMed  Google Scholar 

  10. Nelson C, Wengreen HJ, Munger RG, Corcoran CD. Dietary folate, vitamin B-12, vitamin B-6 and incident Alzheimer’s disease: the Cache County Memory, Health and Aging Study. J Nutr Health Aging. 2009;13:899–905.

    Article  CAS  PubMed  Google Scholar 

  11. Lefevre-Arbogast S, Feart C, Dartigues JF, Helmer C, Letenneur L, Samieri C. Dietary B vitamins and a 10-year risk of dementia in older persons. Nutrients. 2016;8:671.

    Article  Google Scholar 

  12. Wang Z, Zhu W, Xing Y, Jia J, Tang Y. B vitamins and prevention of cognitive decline and incident dementia: a systematic review and meta-analysis. Nutr Rev. 2021;80:931–49.

    Article  Google Scholar 

  13. Kimura Y, Yoshida D, Ohara T, Hata J, Honda T, Hirakawa Y, et al. Long-term association of vegetable and fruit intake with risk of dementia in Japanese older adults: the Hisayama study. BMC Geriatr. 2022;22:257.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Wang Y, Mi N, Liao K, Li Y, Sun Y, Xie P. et al. Associations among dietary 1-carbon metabolism nutrients, genetic risk, and Alzheimer disease: a prospective cohort study. Am J Clin Nutr. 2024;120:1009–18.

    Article  CAS  PubMed  Google Scholar 

  15. Yamagishi K, Muraki I, Kubota Y, Hayama-Terada M, Imano H, Cui R, et al. The Circulatory Risk in Communities Study (CIRCS): a long-term epidemiological study for lifestyle-related disease among Japanese men and women living in communities. J Epidemiol. 2019;29:83–91.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Ikeda A, Yamagishi K, Tanigawa T, Cui R, Yao M, Noda H, et al. Cigarette smoking and risk of disabling dementia in a Japanese rural community: a nested case-control study. Cerebrovasc Dis. 2008;25:324–31.

    Article  PubMed  Google Scholar 

  17. Noda H, Yamagishi K, Ikeda A, Asada T, Iso H. Identification of dementia using standard clinical assessments by primary care physicians in Japan. Geriatr Gerontol Int. 2018;18:738–44.

    Article  PubMed  Google Scholar 

  18. Iso H, Terao A, Kitamura A, Sato S, Naito Y, Kiyama M, et al. Calcium intake and blood pressure in seven Japanese populations. Am J Epidemiol. 1991;133:776–83.

    Article  CAS  PubMed  Google Scholar 

  19. Ministry of Education, Culture, Sports, Science and Technology. Standard tables of food compusition in Japan. Japan: Official Gazette Co-operation of Japan; 2015.

  20. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65:1220S–8S. discussion 9S-31S.

    Article  CAS  PubMed  Google Scholar 

  21. Imano H, Iso H, Kiyama M, Yamagishi K, Ohira T, Sato S, et al. Non-fasting blood glucose and risk of incident coronary heart disease in middle-aged general population: the Circulatory Risk in Communities Study (CIRCS). Prev Med. 2012;55:603–7.

    Article  PubMed  Google Scholar 

  22. Qin B, Xun P, Jacobs DR Jr, Zhu N, Daviglus ML, Reis JP, et al. Intake of niacin, folate, vitamin B-6, and vitamin B-12 through young adulthood and cognitive function in midlife: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Clin Nutr. 2017;106:1032–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Guenther BD, Sheppard CA, Tran P, Rozen R, Matthews RG, Ludwig ML. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nat Struct Biol. 1999;6:359–65.

    Article  CAS  PubMed  Google Scholar 

  24. Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr. 2001;73:613–21.

    Article  CAS  PubMed  Google Scholar 

  25. McNulty H, Dowey le RC, Strain JJ, Dunne A, Ward M, Molloy AM, et al. Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism. Circulation. 2006;113:74–80.

    Article  CAS  PubMed  Google Scholar 

  26. Wilson CP, McNulty H, Ward M, Strain JJ, Trouton TG, Hoeft BA, et al. Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to intervention with riboflavin: findings of a targeted randomized trial. Hypertension. 2013;61:1302–8.

    Article  CAS  PubMed  Google Scholar 

  27. Ashoori M, Saedisomeolia A. Riboflavin (vitamin B(2)) and oxidative stress: a review. Br J Nutr. 2014;111:1985–91.

    Article  CAS  PubMed  Google Scholar 

  28. Betz AL, Ren XD, Ennis SR, Hultquist DE. Riboflavin reduces edema in focal cerebral ischemia. Acta Neurochir Suppl. 1994;60:314–7.

    CAS  PubMed  Google Scholar 

  29. Hoane MR, Wolyniak JG, Akstulewicz SL. Administration of riboflavin improves behavioral outcome and reduces edema formation and glial fibrillary acidic protein expression after traumatic brain injury. J Neurotrauma. 2005;22:1112–22.

    Article  PubMed  Google Scholar 

  30. Durga J, van Boxtel MP, Schouten EG, Kok FJ, Jolles J, Katan MB, et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet. 2007;369:208–16.

    Article  CAS  PubMed  Google Scholar 

  31. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med. 1999;340:1449–54.

    Article  CAS  PubMed  Google Scholar 

  32. Jayedi A, Zargar MS. Intake of vitamin B6, folate, and vitamin B12 and risk of coronary heart disease: a systematic review and dose-response meta-analysis of prospective cohort studies. Crit Rev Food Sci Nutr. 2019;59:2697–707.

    Article  CAS  PubMed  Google Scholar 

  33. Ntaios G, Savopoulos C, Grekas D, Hatzitolios A. The controversial role of B-vitamins in cardiovascular risk: an update. Arch Cardiovasc Dis. 2009;102:847–54.

    Article  PubMed  Google Scholar 

  34. Kishida R, Yamagishi K, Ikeda A, Hayama-Terada M, Shimizu Y, Muraki I. et al. Serum folate and risk of disabling dementia: a community-based nested case-control study. Nutr Neurosci. 2024;27:470–76.

    Article  CAS  PubMed  Google Scholar 

  35. Hsu CY, Chiu SW, Hong KS, Saver JL, Wu YL, Lee JD, et al. Folic acid in stroke prevention in countries without mandatory folic acid food fortification: a meta-analysis of randomized controlled trials. J Stroke. 2018;20:99–109.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Yamagishi K, Maruyama K, Ikeda A, Nagao M, Noda H, Umesawa M, et al. Dietary fiber intake and risk of incident disabling dementia: the Circulatory Risk in Communities Study. Nutr Neurosci. 2023;26:148–55.

    Article  CAS  PubMed  Google Scholar 

  37. Ministry of Health, Labour and Welfare. Long-term Care Need Certification. 2004. https://www.mhlw.go.jp/topics/kaigo/kaigi/040219/2-2d.html.

  38. Ministry of Health, Labour and Welfare. Certification of long-term care need. 2025. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hukushi_kaigo/kaigo_koureisha/nintei/index.html.

  39. Ministry of Health, Labour and Welfare. The National Health and Nutrition Survey in Japan. 2001. https://www.mhlw.go.jp/toukei/kouhyo/indexkk_14_8.html.

Download references

Acknowledgements

The authors thank the healthcare staff of Ikawa, Yao, and Kyowa. The authors would also like to thank Thomas Mayers of the Medical English Communication Center, University of Tsukuba, for language revision.

Funding

This study was partly supported by Health and Labour Science Research Grants for Dementia grant numbers H21-Ninchisho-Wakate-007 and H24-Ninchisho-Wakate-003, and for Comprehensive Research on Cardiovascular Disease and Life–Related Disease grant numbers 20FA1002 and 23FA1006, Ministry of Health, Labour and Welfare, Japan; JSPS KAKENHI grant numbers 26253043, 17H04121, 18H04077, 18K10097, 21H03194, 23K21515 and 25H01090; and Japan FULLHAPP.

Author information

Authors and Affiliations

Authors

Contributions

Conception and design of the study: RK, KY, and H Iso; Analysis of data: RK; Drafting the article: RK, KY, and H Iso; Involved in data collection, interpretation of the data, and critical revision of the manuscript: RK, KY, KM, AI, MS, MT, CO, YK, MH, YS, IM, MU, H Imano, TS, TO, AK, MK, H Iso.

Corresponding author

Correspondence to Kazumasa Yamagishi.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

The institutional review boards of the Osaka Institute of Public Health (No. 2409-02), Kindai University (No. R04-255), Osaka University (No. 14285-13), and University of Tsukuba (No. 2047-1) approved the study procedure. This study conformed to the principles of the Declaration of Helsinki. Informed consent was obtained from community leaders. Based on the nature of the study as a secondary use of data initially obtained for public health practice on cardiovascular disease prevention within the local community, individual consent was not required for the analysis. In compliance with relevant guidelines and regulations, the participants were retrospectively allowed to opt out of the analysis. If participants did not decline participation in this study, their consent for data usage was assumed.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kishida, R., Yamagishi, K., Maruyama, K. et al. Dietary intake of folate, vitamin B6, vitamin B12, and riboflavin and the risk of incident dementia. Eur J Clin Nutr (2025). https://doi.org/10.1038/s41430-025-01663-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41430-025-01663-5

Search

Quick links